Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J David Lawson

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Protein Science : a Publication of the Protein Society|December 24, 2003
Protein flexibility and intrinsic disorderPredrag Radivojac, Zoran Obradovic, David K Smith, et al.
Journal of Medicinal Chemistry|June 19, 2015
Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine KinaseChristopher R Smith, Douglas R Dougan, Mallareddy Komandla, et al.
The Journal of Biological Chemistry|November 26, 2002
Structural model of the regulatory domain of smooth muscle heavy meromyosinJan L Wahlstrom, M Allen Randall, J David Lawson, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2016
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 2Christopher McBride, Zacharia Cheruvallath, Mallareddy Komandla, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine KinasesHidehisa Iwata, Hideyuki Oki, Kengo Okada, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2017
Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogateWalter Keung, Amogh Boloor, Jason Brown, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2015
Fragment-based drug discovery of potent and selective MKK3/6 inhibitorsMark Adams, Toshitake Kobayashi, J David Lawson, et al.
Bioinformatics (Oxford, England)|August 18, 2004
DisProt: a database of protein disorderSlobodan Vucetic, Zoran Obradovic, Vladimir Vacic, et al.
Journal of Medicinal Chemistry|August 27, 2021
Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (<i>S</i>)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3<i>H</i>-1,2,4-triazol-3-one, by Fragment-Based Drug DesignMark Sabat, Douglas R Dougan, Beverly Knight, et al.
Journal of Chemical Information and Modeling|October 17, 2024
Exploration of Cryptic Pockets Using Enhanced Sampling Along Normal Modes: A Case Study of KRAS <sup>G12D</sup>Neha Vithani, She Zhang, Jeffrey P Thompson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Protein Science : a Publication of the Protein Society|December 24, 2003
Protein flexibility and intrinsic disorderPredrag Radivojac, Zoran Obradovic, David K Smith, et al.
Journal of Medicinal Chemistry|June 19, 2015
Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine KinaseChristopher R Smith, Douglas R Dougan, Mallareddy Komandla, et al.
The Journal of Biological Chemistry|November 26, 2002
Structural model of the regulatory domain of smooth muscle heavy meromyosinJan L Wahlstrom, M Allen Randall, J David Lawson, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2016
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 2Christopher McBride, Zacharia Cheruvallath, Mallareddy Komandla, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine KinasesHidehisa Iwata, Hideyuki Oki, Kengo Okada, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2017
Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogateWalter Keung, Amogh Boloor, Jason Brown, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2015
Fragment-based drug discovery of potent and selective MKK3/6 inhibitorsMark Adams, Toshitake Kobayashi, J David Lawson, et al.
Bioinformatics (Oxford, England)|August 18, 2004
DisProt: a database of protein disorderSlobodan Vucetic, Zoran Obradovic, Vladimir Vacic, et al.
Journal of Medicinal Chemistry|August 27, 2021
Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (<i>S</i>)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3<i>H</i>-1,2,4-triazol-3-one, by Fragment-Based Drug DesignMark Sabat, Douglas R Dougan, Beverly Knight, et al.
Journal of Chemical Information and Modeling|October 17, 2024
Exploration of Cryptic Pockets Using Enhanced Sampling Along Normal Modes: A Case Study of KRAS <sup>G12D</sup>Neha Vithani, She Zhang, Jeffrey P Thompson, et al.
Pageof 4